You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
樂普醫療(300003.SZ):三款雷帕黴素洗脱支架系統取得歐盟CE產品註冊證
格隆匯 11-09 16:10

格隆匯 11 月 9日丨樂普醫療(300003.SZ)公佈,公司不斷加快國際化發展戰略的實施,公司自主研發的三款藥物支架——血管內藥物(雷帕黴素)洗脱支架系統(商品名:Partner)、鈷基合金雷帕黴素洗脱支架系統(商品名:GuReater)、血管內無載體含藥(雷帕黴素)洗脱支架系統(商品名:Nano+)近日獲得歐盟CE證書。CE證書由歐盟NB機構審核通過後正式頒發。

在日益嚴峻的歐盟新法規監管形式下,樂普醫療核心產品的成功獲證表明在各方面技術指標能夠持續滿足最新歐盟法規的要求。上述工作的完成,增強了藥物支架系列產品的市場競爭力,在國家醫保藥品和器械集採等政策下,公司加快調整核心產品銷售策略,將加快公司開拓國際市場的步伐,為全面實施公司國際化戰略奠定堅實的基礎,為公司總體的經營成長起到了積極正面的影響,同時為全球心血管患者帶來更多的選擇和福音。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account